Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Safety issues associated with Pivanex plus docetaxel in phase IIb study

June 28, 2004

New antitumor agents developed by Sanofi-Synthelabo scientists

June 25, 2004

Roche claims two series of protein kinase inhibitors for use in cancer therapy

June 25, 2004

XenoPort presents new gemcitabine prodrugs

June 25, 2004

Immusol initiates collaboration with Affymetrix for oncology drug discovery

June 25, 2004

FDA lifts clinical hold on phase I NHL study of PPI-2458

June 25, 2004

Good safety profile reported for AP-23573 in patients with refractory tumors

June 25, 2004

New European approval for Herceptin

June 25, 2004

Metabolic conversion of anticancer agent SD-2007 to apicidin in rats

June 25, 2004

Bevacizumab demonstrates substantial clinical activity

June 25, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...